Advanced Micro-Fabrication Equipment (688012) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
29 Aug, 2025Executive summary
Achieved record revenue of RMB 4.96 billion in H1 2025, up 43.88% year-over-year, with net profit attributable to shareholders of RMB 706 million, up 36.62%.
Main growth drivers: plasma etching equipment sales (RMB 3.78 billion, up 40.12%) and LPCVD equipment (RMB 199 million, up 608.19%).
R&D investment reached RMB 1.49 billion, up 53.70% year-over-year, accounting for 30.07% of revenue.
Company continues to expand product lines, accelerate new product development, and strengthen global market presence.
Financial highlights
Revenue: RMB 4.96 billion (up 43.88% YoY); net profit: RMB 706 million (up 36.62% YoY).
Gross margin increased due to higher sales and product mix; R&D expenses up 96.65% YoY.
Operating cash flow: RMB 203 million (down 46.87% YoY); total assets: RMB 28.42 billion (up 8.40% from year-end 2024).
Basic EPS: RMB 1.13 (up 34.52% YoY); weighted average ROE: 3.49%.
Non-recurring gains: RMB 167 million, mainly from fair value changes in financial assets.
Outlook and guidance
Management targets continued high growth through organic expansion and M&A, aiming to cover 50–60% of high-end semiconductor equipment market in 5–10 years.
Focus on advanced logic, memory, and compound semiconductor equipment; expects further market share gains.
R&D speed and product launch cycles to further accelerate.
Latest events from Advanced Micro-Fabrication Equipment
- Revenue up 36.46%, net profit down 48.48% as R&D investment more than doubled.688012
Q2 202415 Dec 2025 - Revenue up 44.73% to ¥9.07B; net profit down 8.93% amid surging R&D investment.688012
Q4 202415 Dec 2025 - Revenue up 46.40% and net profit up 32.66% year-over-year, with robust R&D growth.688012
Q3 202530 Oct 2025 - Q3 net profit jumped 153% on robust etching equipment sales and investment gains.688012
Q3 202413 Jun 2025 - Q1 2025 revenue up 35.4%, net profit up 25.7%, R&D investment up 90.5%.688012
Q1 20256 Jun 2025